Ethereum drops below $2,500 as analysts eye $1,600–$1,800 zone, while ETF outflows and BitMine losses deepen pressure. Ethereum continued its decline on TuesdayEthereum drops below $2,500 as analysts eye $1,600–$1,800 zone, while ETF outflows and BitMine losses deepen pressure. Ethereum continued its decline on Tuesday

Ethereum Price Warning: $1,600-$1,800 Could Be the Smart Entry Zone

3 min read

Ethereum drops below $2,500 as analysts eye $1,600–$1,800 zone, while ETF outflows and BitMine losses deepen pressure.

Ethereum continued its decline on Tuesday, trading below $2,500 amid broader crypto market weakness.

Analysts now warn that deeper downside remains possible, with several pointing to lower price zones.

The sell-off has increased unrealized losses for large holders, including Tom Lee’s BitMine, while on-chain data shows rising exchange inflows.

Analysts warn Ethereum could test lower price zones

Several analysts have outlined downside targets as Ethereum extends its pullback.

Analyst Jake Wujastyk said Ethereum could trade between $1,800 and $1,850 if selling pressure accelerates.

His comments followed Bitcoin’s recent decline, which triggered large liquidations across the market.

Another market analyst, G. Martin, said Ethereum’s higher timeframe structure still appears stronger than Bitcoin’s.

However, he noted that current price action and technical signals continue to point toward a sustained downtrend. He added that Ethereum often follows Bitcoin’s broader market direction.

Martin also identified potential support zones if the decline continues. He said the $2,000 to $2,200 range could attract buyers.

He added that the $1,600 to $1,800 zone could become a key area if market stress deepens.

Whale activity and exchange flows increase pressure

On-chain data shows increased whale activity during the recent decline. Reports indicated that Ethereum co-founder Vitalik Buterin moved ETH worth about $44 million.

The transfer occurred while prices remained under pressure across major exchanges.

Other large holders also moved funds to exchanges. On-chain analytics firm Lookonchain reported that Garrett Jin deposited over 3,000 ETH into Binance.

The transfer followed the liquidation of his large ETH long position earlier in the day.

Another analyst, Ali, reported that more than 60,000 ETH moved to exchanges within 72 hours.

These transfers coincided with sharp price drops. The data suggests that selling pressure has remained steady rather than isolated.

Related Reading: $12.4M Gone: Ethereum Whale Tricked by Fake Galaxy Address

BitMine losses and ETF outflows add to weakness

Tom Lee’s BitMine has seen its unrealized loss grow to about $6 billion following Ethereum’s decline.

BitMine began accumulating ETH when prices were near $2,540 in early 2025. Ethereum has since fallen below those levels.

This week, BitMine acquired more than 40,000 ETH, increasing its exposure. Reports show the firm holds around 3.5% of Ethereum’s circulating supply.

The recent price drop has reduced the value of these holdings.

ETF data also shows continued outflows. According to SoSoValue, spot Ethereum ETFs recorded a weekly net outflow of $327 million.

These withdrawals added to downward pressure during the sell-off.

Exchange netflow data provides further context. Ethereum began declining from $3,100 as outflows increased in late January.

Sharp withdrawals aligned with price drops toward $2,400, reinforcing short-term weakness.

The post Ethereum Price Warning: $1,600-$1,800 Could Be the Smart Entry Zone appeared first on Live Bitcoin News.

Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact service@support.mexc.com for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

Bitcoin ETFs Outpace Ethereum With $2.9B Weekly Surge

Bitcoin ETFs Outpace Ethereum With $2.9B Weekly Surge

The surge follows a difficult August, when investors pulled out more than $750 million while rotating capital into Ethereum-focused funds. […] The post Bitcoin ETFs Outpace Ethereum With $2.9B Weekly Surge appeared first on Coindoo.
Share
Coindoo2025/09/18 01:15
CME Group to launch options on XRP and SOL futures

CME Group to launch options on XRP and SOL futures

The post CME Group to launch options on XRP and SOL futures appeared on BitcoinEthereumNews.com. CME Group will offer options based on the derivative markets on Solana (SOL) and XRP. The new markets will open on October 13, after regulatory approval.  CME Group will expand its crypto products with options on the futures markets of Solana (SOL) and XRP. The futures market will start on October 13, after regulatory review and approval.  The options will allow the trading of MicroSol, XRP, and MicroXRP futures, with expiry dates available every business day, monthly, and quarterly. The new products will be added to the existing BTC and ETH options markets. ‘The launch of these options contracts builds on the significant growth and increasing liquidity we have seen across our suite of Solana and XRP futures,’ said Giovanni Vicioso, CME Group Global Head of Cryptocurrency Products. The options contracts will have two main sizes, tracking the futures contracts. The new market will be suitable for sophisticated institutional traders, as well as active individual traders. The addition of options markets singles out XRP and SOL as liquid enough to offer the potential to bet on a market direction.  The options on futures arrive a few months after the launch of SOL futures. Both SOL and XRP had peak volumes in August, though XRP activity has slowed down in September. XRP and SOL options to tap both institutions and active traders Crypto options are one of the indicators of market attitudes, with XRP and SOL receiving a new way to gauge sentiment. The contracts will be supported by the Cumberland team.  ‘As one of the biggest liquidity providers in the ecosystem, the Cumberland team is excited to support CME Group’s continued expansion of crypto offerings,’ said Roman Makarov, Head of Cumberland Options Trading at DRW. ‘The launch of options on Solana and XRP futures is the latest example of the…
Share
BitcoinEthereumNews2025/09/18 00:56
The FDA Is Trying To Make Corporate Free Speech Situational

The FDA Is Trying To Make Corporate Free Speech Situational

The post The FDA Is Trying To Make Corporate Free Speech Situational appeared on BitcoinEthereumNews.com. BENSENVILLE, ILLINOIS – SEPTEMBER 10: Flanked by U.S. Attorney General Pam Bondi (rear), and FDA Commissioner Marty Makary (R), Secretary of Health and Human Services Robert F. Kennedy Jr. speaks to the press outside Midwest Distribution after it was raided by federal agents on September 10, 2025 in Bensenville, Illinois. According to the company, various e-liquids were seized in the raid. (Photo by Scott Olson/Getty Images) Getty Images While running for President in 2008, Barack Obama famously chanted “Yes we can.” Love or hate his political views, Obama’s politics were quite effective. He was asking voters to think big, to envision a much better future. Advertisers no doubt approved. That’s because ads routinely evoke things not as they are, but as they could be. Gyms and exercise equipment companies don’t promote their locations and equipment with flabby, lumbering people, rather their ads show fit, upright, energetic individuals. A look ahead. Restaurants do the same with ads showing happy people enjoying impressively put together plates of food. Conversely, ads meant to convince smokers to quit have not infrequently shown the worst of the worst future downsides of the habit. The nature of advertising comes to mind as FDA commissioner Marty Makary puzzlingly brags that “The Trump Administration Is Taking On Big Pharma” in the New York Times. Makary laments pharmaceutical ads that “are filled with dancing patients, glowing smiles and catch jingles that drown out the fine print.” Not explained is whether Makary would be happier if drug companies placed ads with immobile patients, frowns, and funereal music. Seriously, what does he expect? Does he want drug companies to commit billions to drug development to accompany their achievements with imagery defined by misery? Has Makary stopped to contemplate the myriad shareholders lawsuits drugmakers would face if, upon risking staggering sums meant…
Share
BitcoinEthereumNews2025/09/18 06:29